Celebrating a new partnership

December 2, 2010 | 4:09 p.m. CST
MU researchers Raghuraman Kannan and Kattesh Katti, Robert Churchill, dean of the MU School of Medicine, and Abhaya Kumar, the founding director of Shasun celebrate the foundation of the new drug development company, Shasun NBI, which will work on further development of a prostate cancer treatment that uses gold nanoparticles.

RELATED STORIES: MU researchers work with Indian firm to develop cancer treatment